Manulife (Manufacturers Life Insurance)
TRIL

Manulife (Manufacturers Life Insurance)’s Trillium Therapeutics Inc. TRIL Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-49,618
Closed -$1.1M – 3223
2021
Q3 		$1.1M Sell
49,618
-91,531
-65% -$1.07M ﹤0.01% 1779
2021
Q2 		$1.7M Buy
141,149
+49,518
+54% +$466K ﹤0.01% 1682
2021
Q1 		$1.23M Buy
91,631
+1,534
+2% +$19K ﹤0.01% 1780
2020
Q4 		$1.69M Buy
90,097
+11,551
+15% +$167K ﹤0.01% 1590
2020
Q3 		$1.49M Buy
+78,546
New +$783K ﹤0.01% 1515

Other funds holding TRIL

Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s TRIL Position: Q4 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 49,618 shares — an estimated $1.1M sold.

Manulife (Manufacturers Life Insurance) first reported a position in TRIL in Q3 2020 and held it in 5 quarters. The position peaked at $1.7M in Q2 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 49,618 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $1.1M.
  • Manulife (Manufacturers Life Insurance) first reported a position in Trillium Therapeutics Inc. in Q3 2020 and held it in 5 quarters.
  • Manulife (Manufacturers Life Insurance)'s Trillium Therapeutics Inc. position peaked at $1.7M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2021, filed 16 Feb 2022.